Soumit Roy analyst JONESTRADING

Currently out of the existing stock ratings of Soumit Roy, 30 are a BUY (75%), 10 are a HOLD (25%).

Soumit Roy

Work Performance Price Targets & Ratings Chart

Analyst Soumit Roy, currently employed at JONESTRADING, carries an average stock price target met ratio of 21.57% that have a potential upside of 44.51% achieved within 48 days.

Soumit Roy’s has documented 70 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on INAB, In8bio  at 11-Feb-2025.

Wall Street Analyst Soumit Roy

Analyst best performing recommendations are on CGEM (CULLINAN ONCOLOGY LLC).
The best stock recommendation documented was for CGEM (CULLINAN ONCOLOGY LLC) at 4/16/2024. The price target of $26 was fulfilled within 13 days with a profit of $8.68 (50.12%) receiving and performance score of 38.55.

Average potential price target upside

DCPH Deciphera Pharmaceuticals LLC INFI Infinity Pharmaceuticals AVEO AVEO Pharmaceuticals SAVA Cassava Sciences SBTX Silverback Therapeutics  IKT Inhibikase Therapeutics  RAIN Rain Therapeutics TCON TRACON Pharmaceuticals MRTX Mirati Ther MNPR Monopar Therapeutics INAB In8bio  CGEM Cullinan Oncology LLC DTIL Precision BioSciences JANX Janux Therapeutics APTO Aptose Biosciences ACRV Acrivon Therapeutics, Common Stock CRVO CervoMed

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$23

$-2.59 (-10.12%)

$23

1 years 1 months 13 days ago
(10-May-2024)

6/9 (66.67%)

$-2.36 (-9.31%)

90

Sell

$26

$0.41 (1.60%)

$9

1 years 1 months 24 days ago
(30-Apr-2024)

3/10 (30%)

$0.73 (2.89%)

235

Hold

$22

1 years 1 months 24 days ago
(30-Apr-2024)

2/3 (66.67%)

$2.24 (11.34%)

67

Hold

$23

1 years 1 months 25 days ago
(29-Apr-2024)

4/6 (66.67%)

$8.58 (59.50%)

352

Hold

$16

$-9.59 (-37.48%)

1 years 1 months 25 days ago
(29-Apr-2024)

0/3 (0%)

$-9.28 (-36.71%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Soumit Roy is most bullish on?

Potential upside of $-0.98 has been obtained for INAB (IN8BIO )

What Year was the first public recommendation made by Soumit Roy?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?